MNLO - Menlo Therapeutics Inc.
Previous close
1.35
1.350 100.000%
Share volume: 0
Last Updated: Fri 04 Sep 2020 10:00:00 PM CEST
Pharmaceuticals: Major:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
17%
Profitability
9%
Dept financing
40%
Liquidity
39%
Performance
15%
Sector
Health Technology
Industry
Pharmaceuticals: Major
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-36.53%
Return on assets
-14.17%
Return on sales
-1245.38%
Return on invested capital
104.73%
Total debt ratio
19.21%
Debt ratio change over timeo
-0.94%
Current Ratio
11.06%
Quick Ratio
3.18%
Cash Position Ratio
4.61%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-107.78%
Return on assets
-22.55%
Return on sales
-1245.38%
Return on invested capital
269.58%
Total debt ratio
38.49%
Debt ratio change over timeo
-0.91%
Current Ratio
4.67%
Quick Ratio
3.18%
Cash Position Ratio
2.65%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-234.09%
Return on assets
-18.88%
Return on sales
-211.38%
Return on invested capital
1320.5%
Total debt ratio
45.33%
Debt ratio change over time
-1.06%
Current Ratio
4.92%
Quick Ratio
4.68%
Cash Position Ratio
4.02%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-105.15%
Return on assets
-105.64%
Return on sales
-606.08%
Return on invested capital
-61.75%
Total debt ratio
-94.08%
Debt ratio change over time
-0.94%
Current Ratio
0.89%
Quick Ratio
-0.94%
Cash Position Ratio
-0.39%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MNLO | FTSV | PRNB | RARX |
|---|---|---|---|---|
| Return on equity | -36.53% | -17.97% | -3.34% | -14.58% |
| Return on assets | -14.17% | -15.67% | -1.22% | -13.27% |
| Return on sales | -1245.38% | 0% | 0% | 0% |
| Return on invested capital | 104.73% | 161.19% | -511.62% | 733.8% |
| Profitability | 4% | 5% | 75% | 25% |
| Total debt ratio | 19.21% | 14.54% | 27.48% | 9.46% |
| Debt ratio change over time | -0.94% | -0.91% | -1.02% | -1% |
| Dept financing | 17% | 38% | 25% | 9% |
| Current Ratio | 4.67% | 11.14% | 16.04% | 20.26% |
| Quick Ratio | 3.18% | 0% | 0% | 0% |
| Cash Position Ratio | 2.65% | 5.36% | 4.16% | 19.67% |
| Liquididy | 51% | 17% | 24% | 50% |
| Short-term ratios | MNLO | FTSV | PRNB | RARX |
|---|---|---|---|---|
| Return on equity | -107.78% | -8.91% | -6.16% | -11.27% |
| Return on assets | -22.55% | -8.75% | -5.93% | -10.9% |
| Return on sales | -1245.38% | 0% | 0% | 0% |
| Return on invested capital | 269.58% | 121.89% | -177.6% | 631.03% |
| Profitability | 11% | 5% | 75% | 25% |
| Total debt ratio | 38.49% | 10.61% | 9.15% | 6.33% |
| Debt ratio change over time | -0.91% | -0.91% | -1.02% | -0.99% |
| Dept financing | 50% | 7% | 6% | 4% |
| Current Ratio | 4.67% | 11.14% | 16.04% | 20.26% |
| Quick Ratio | 3.18% | 0% | 0% | 0% |
| Cash Position Ratio | 2.65% | 5.36% | 4.16% | 19.67% |
| Liquididy | 34% | 21% | 25% | 50% |